MonitorDirect · GrowthWatch before adding
Invesco India Large & Mid Cap Fund
Invesco Mutual FundEquity Schemes - Large & Mid Cap Fund13.8 years
The scheme seeks to generate capital appreciation from a diversified portfolio of predominantly Equity and Equity Related Instruments of Large and Midcap companies.
- NAV
- 124.79
- 29 Oct 2026
- 1Y
- +0.8%
- Trailing CAGR
- AUM
- ₹11,746.4 Cr
- 31 Aug 2026
- Volatility
- Medium
- 15.9% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Three-year return is above the category median.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer Axis Large & Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -35.3%. Ask whether you can hold through a similar fall.
Vs category
Watch
42% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Deepak Gupta · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 54.7% of the portfolio.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 35%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+0.8%
- 3Y+21.3%
- 5Y+15.8%
- 10Y+16.8%
- SI+17.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+6.6%
- 3Y+11.2%
- 5Y+17.4%
- 10Y+17.5%
- Since inception
- +17.3%
- Calendar-day CAGR
- Excess 1Y
- +4.3%
- Category median, same plan and option
- 3Y win rate
- +42%
- Windows beating the median
- 3Y percentile
- 100
- Vs comparable share classes
- SIP 3Y XIRR
- +11.2%
- Simulated monthly SIP
- Worst rolling 3Y
- -1.2%
- 2653 daily-ending windows
- Median rolling 3Y
- +18.2%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2160 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -35.3%
- Worst peak-to-trough
- Current
- -7.0%
- Below last peak
- Current spell
- 87 days
- Days below latest peak
- Time below peak
- +84%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 12 days
- 193 recovered episodes
- Longest recovery
- 368 days
- Trough to prior peak
20 Feb 2020 – 13 Nov 2020
Trough 23 Mar 2020 · recovered in 235 days
-35.3%
17 Jan 2022 – 1 Dec 2022
Trough 20 Jun 2022 · recovered in 164 days
-19.9%
6 Aug 2015 – 12 Jul 2016
Trough 25 Feb 2016 · recovered in 138 days
-19.0%
24 Sept 2024 – 6 Jun 2025
Trough 28 Feb 2025 · recovered in 98 days
-18.6%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
77
Consistency
41
Risk-adjusted
62
Drawdown
12
Mean
58
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Maximum drawdown exceeded 35%.
Supporting reads
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
31 Aug 2026 · 44 holdings · top 10 are 54.7%.
- Top 5
- 34.7%
- Top 10
- 54.7%
- Largest holding
- 8.3%
- Effective holdings
- 24.1
Zomato Ltd
Technology
8.3%
Interglobe Aviation Ltd
Industrials
7.6%
ICICI Bank Ltd
Financial
7.5%
Max Healthcare Institute Ltd
Healthcare
6.6%
Sai Life Sciences Ltd.
Healthcare
5.1%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Large & Mid Cap Fund
Axis Mutual Fund
- 1Y
- -0.3%
- 3Y
- +14.9%
- Vol
- 14.6%
- Max DD
- -31.9%
- Sharpe
- 0.81
- 3Y win
- +50%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
JM Large & Mid Cap Fund
JM Financial Mutual Fund
- 1Y
- -3.4%
- 3Y
- n/a
- Vol
- 14.4%
- Max DD
- -15.5%
- Sharpe
- -0.22
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
WhiteOak Capital Large & Mid Cap Fund
WhiteOak Capital Mutual Fund
- 1Y
- -2.5%
- 3Y
- n/a
- Vol
- 14.5%
- Max DD
- -16.0%
- Sharpe
- 0.43
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
Helios Large & Mid Cap Fund
Helios Mutual Fund
- 1Y
- -2.2%
- 3Y
- n/a
- Vol
- 15.9%
- Max DD
- -18.0%
- Sharpe
- 0.08
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Higher TER · Lower trailing returns
Mahindra Manulife Large & Mid Cap Fund
Mahindra Manulife Mutual Fund
- 1Y
- -1.9%
- 3Y
- +12.1%
- Vol
- 17.7%
- Max DD
- -32.9%
- Sharpe
- 0.68
- 3Y win
- +44%
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Higher TER · Lower trailing returns